Home › Encyclopedia › Capromorelin: Uses, Mechanism, and Research Status
Approved

Capromorelin: Uses, Mechanism, and Research Status

Molecular formulaC28H35N5O4
Molecular weight505.6 g/mol
Registered trials0
PubChem CID216208

Anyone researching capromorelin usually wants to know what it is and how much clinical evidence backs it. This overview lays out what is verifiable from available data sources.

What capromorelin is

Capromorelin is a small molecule compound identified by PubChem CID 216208, with the molecular formula C28H35N5O4 and a molecular weight of approximately 505.6 g/mol. No FDA drug label information is available for this compound in the data reviewed here, so no approved indications, mechanism of action summary, or brand names can be reported.

Regulatory and research status

Capromorelin is an approved compound. Beyond confirming approval status, this summary does not have label details such as pharm class or mechanism text to draw from, so those aspects are omitted here.

What the evidence shows

No registered clinical trials are recorded in the dataset reviewed for capromorelin, and no trial sample records are available. As a result, no phase, status, or study details can be summarized at this time.

FAQ

What is capromorelin?
Capromorelin is a small molecule compound with the molecular formula C28H35N5O4 and a molecular weight of about 505.6 g/mol. It is catalogued in PubChem under CID 216208. Detailed label information such as mechanism of action or approved indications is not available in current data.
Is capromorelin FDA approved?
Capromorelin holds approved status. However, specific label details, including approved indications and brand names, are not available in the data reviewed here.
How many clinical trials have studied capromorelin?
The data reviewed shows no registered clinical trials for capromorelin. No trial sample records, phases, or statuses are available to summarize.
What side effects are reported for capromorelin?
No adverse event reports are available in the dataset reviewed for capromorelin. As a result, no side effect pattern can be summarized at this time.
What is the chemical structure of capromorelin?
Capromorelin has the molecular formula C28H35N5O4 and a molecular weight of approximately 505.6 g/mol. Its structure and identifiers are catalogued in PubChem under CID 216208.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem DailyMed ClinicalTrials.gov FAERS

Updated 2026-09-19